+ Watch JGBO
on My Watchlist
This is a tracking portfolio of all CAPS-ratable tickers in the Chinese RTO/SPAC space (i.e., companies that listed without filing an IPO).Jiangbo Pharmaceuticals, Inc. went public via a reverse merger in 2007. The company is based in China.
Price/earnings of 1.11, Price/book of 0.33, Debt/equity ratio of 0.17, Return on Invested Capital (TTM) of 27.55, marketing and sale of pharmaceutical products in China.
Could easily see $20 IF confidence in accounting strengthens. Bail at $12 to be cautious.
low p/e, good P/BV, strong balance sheet. Good company in a growing economy. I wanna bet some dollars on this company
Solid Financials - Chinese small cap to scary?
The beatings on chinese stocks will continue until morale imporves!
pretty nutty breakdown:http://seekingalpha.com/article/244721-best-bargain-stock-in-america-it-could-be-jiangbo?source=qp_article
Ok I'll bite. Currently trading over 20% below net cash liquidation value. As long as results can be trusted, and so far there are no signs they can't, Jiangbo will make somewhere in the ballpark of $1.45-$1.65 in 2011, or roughly less than 4 times current earnings. Well below book value and a few new products coming to market. The main reason it's getting clobbered outside of the usual China woes is the fact that it breached a debt covenant thanks to good ole Communist China's inability to get them their cash and revenue guidance missed expectations by a clean 20%. Even with revenue growth of 10-15% this is heavily underappreciated. The least they could do is trade within 5% of their cash value.TMFUltraLong
Completely beaten down. Had a rough quarter but I feel they will bounce back. At this price with these fundamentals its almost impossible not to buy this. Plus it's currently trading under it's net current asset value!
Get in @7.30. This is like buying its $6.50 cash with a good business
PE of between 3 and 9.... assuming no fraud...
Chinese Medicine...mmmmmm......Current PE 4Forward PE 5.79Estimated Revenue Growth 6%
JGBO is Jiangbo Pharma a USA China stockChina is a growing economy even in recession.JGBO cash in the bank growing yearly by $40+ million.Rate of growth exceeds 50% per year.Has $76 million cash plus >$10 stock price qualifies for NAZDAQ. JGBO plans to be on NAZDAQ in 2009.10K due Sept 30, 2009Will be an Accredited Filer Jan 1, 2010Looking for $20.00+ in one year or less
Very cheap based on current cash flow.
I think I've got this one figured out - took a bit of legwork, but here's the scam:Have the company issue a bunch of convertible warrants to you and your friends. They pay interest if nothing else. Let's make it 1/3 of your market cap in warrants though.Set an option for early conversion if the share price goes above X, where X is a big number.Some time later have your partner companies start funneling money into you at a rapidly increasing rate. YoY income, profits, EPS starts accelerating.If the stock price goes up, convert your warrants into shares and dilute the crap out of the stock.From Form 8-K"Wubo Cao ("Mr. Cao") and certain investors (the "Investors"), pursuant to which, on May 30, 2008, the Company sold to the Investors 6% convertible notes (the "Notes") and warrants to purchase shares of the Company's common stock ("Warrants") for the aggregate amount of $30,000,000 (the "Purchase Price")" - Note that the company didn't even have $100M market cap at that time."The Notes are convertible at the option of the Company if the following four conditions are met: (i) effectiveness of a registration statement with respect to the shares of the Company's common stock underlying the Notes and the Warrants; (ii) the VWAP of the common stock has been equal to or greater than 250% of the conversion price, as adjusted, for 20 consecutive trading days on its principal trading market; (iii) the average dollar trading volume of the common stock exceeds $500,000 on its principal trading market for the same 20 days; and (iv) the Company achieves 2008 Guaranteed EBT (as hereinafter defined) and 2009 Guaranteed EBT (as hereinafter defined). A holder of a Note may require the Company to redeem all or a portion of such Note for cash at a redemption price as set forth in the Notes, in the event of a change in control of the Company, an event of default or if any governmental agency in the People's Republic of China challenges or takes action that would adversely affect the transactions contemplated by the Securities Purchase Agreement." - 250% of $8 per share (adjusted for a 1:40 reverse split) is $20 per share.Blamo...Payday! Horray for everyone except those that got duped into buying JGBO.OB shares. Please let me know if I screwed this one up.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions